| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.35B | 45.85B | 38.70B | 35.35B | 29.14B | 56.47B |
| Gross Profit | 16.84B | 16.89B | 14.39B | 12.41B | 10.15B | 13.09B |
| EBITDA | 11.01B | 12.06B | 9.79B | 12.65B | 4.04B | -1.54B |
| Net Income | 8.66B | 8.70B | 6.56B | 9.48B | 336.00M | -6.34B |
Balance Sheet | ||||||
| Total Assets | 128.44B | 130.17B | 125.76B | 176.11B | 188.85B | 198.87B |
| Cash, Cash Equivalents and Short-Term Investments | 10.98B | 12.39B | 14.60B | 20.91B | 23.42B | 28.07B |
| Total Debt | 20.28B | 20.49B | 20.38B | 21.76B | 26.15B | 38.03B |
| Total Liabilities | 110.15B | 111.27B | 106.20B | 147.50B | 153.94B | 157.11B |
| Stockholders Equity | 18.06B | 18.68B | 19.34B | 27.40B | 33.70B | 40.31B |
Cash Flow | ||||||
| Free Cash Flow | 7.47B | 7.26B | 3.68B | 3.58B | 4.74B | 2.37B |
| Operating Cash Flow | 8.85B | 8.54B | 4.71B | 5.18B | 5.92B | 3.48B |
| Investing Cash Flow | -1.75B | -1.15B | -1.67B | 3.98B | 2.27B | 21.38B |
| Financing Cash Flow | -9.23B | -8.68B | -6.73B | -8.61B | -5.58B | -45.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $93.91B | 21.10 | 17.41% | 1.73% | 9.35% | 10.49% | |
68 Neutral | $319.08B | 38.03 | 46.39% | 0.48% | 21.75% | 26.48% | |
68 Neutral | $238.01B | 31.57 | 11.23% | 1.44% | 10.56% | 56.63% | |
67 Neutral | $79.48B | 27.70 | 28.05% | 1.55% | 4.95% | 26.05% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | $118.57B | 23.12 | 74.53% | 2.77% | 4.59% | -10.76% | |
53 Neutral | $181.25B | -10,177.67 | -8719.23% | ― | 32.74% | ― |